semaglutide weight loss average Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Semaglutide sustains lower calorie intake

Clinical trials have demonstrated that semaglutide produces substantial weight loss when combined with lifestyle modifications including reduced caloric intake and increased physical activity

In other words, you would receive one month (4 injections) of 0.25 mg, one month (4 injections) of 0.5 mg, and so forth to 1.0 mg, 1.7 mg, and finally 2.4 mg, assuming your side effects are minimal

Patients should be aware of important warning signs requiring medical attention: persistent severe abdominal pain with or without vomiting (possible pancreatitis), right upper quadrant pain/fever/jaundice (possible gallbladder disease), reduced urination or dizziness (possible dehydration/kidney issues), visual changes (especially in diabetes patients), or allergic reactions

Semaglutide is a long-acting GLP-1 receptor agonist that mimics the action of the naturally occurring incretin hormone GLP-1